Complement component C1q modulates the phagocytosis of Aβ by microglia

Experimental Neurology

Volumn 161, Issue 1, 2000, Pages 127-138

  Webster, Scott D ^a   Yang, Austin J ^b   Margol, Larry ^a   Garzon Rodriguez, William ^a   Glabe, Charles G ^a   Tenner, Andrea J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid beta peptide; Complement protein C1q; Microglia; Phagocytosis

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENT COMPONENT C1Q; SCAVENGER RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL INTERACTION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; INFLAMMATION; INTERNALIZATION; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

EID: 0034050540     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7260     Document Type: Article

References (81)

1. Acton S., Resnick D., Freeman M., Ekkel Y., Ashkenas J., Krieger M. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J. Biol. Chem. 268:1993;3530-3537.
2. Afagh A., Cummings B. J., Cribbs D. H., Cotman C. W., Tenner A. J. Localization and cell association of C1q in Alzheimer's disease brain. Exp. Neurol. 138:1996;22-32.
3. Ard M. D., Cole G. M., Wei J., Mehrle A. P., Fratkin J. D. Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J. Neurosci. Res. 43:1996;190-202.
4. Barnum S. R. Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med. 6:1995;132-146.
5. Bradt B. M., Kolb W. P., Cooper N. R. Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J. Exp. Med. 188:1998;431-438.
6. Burdick D., Kosmoski J., Knauer M. F., Glabe C. G. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1-42, in differentiated PC12 cells. Brain Res. 746:1997;275-284.
7. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
8. Chaney M. O., Webster S. D., Kuo Y. M., Roher A. E. Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease. Protein Eng. 11:1998;761-767.
9. Chen S., Frederickson R. C., Brunden K. R. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: Complement activation and therapeutic approaches. Neurobiol. Aging. 17:1996;781-787.
10. Chu T., Tran T., Yang F., Beech W., Cole G. M., Frautschy S. A. Effect of chloroquine and leupeptin on intracellular accumulation of amyloid-beta (A beta) 1-42 peptide in a murine N9 microglial cell line. FEBS Lett. 436:1998;439-444.
11. Delgado R., Carlin A., Airaghi L., Demitri M. T., Meda L., Galimberti D., Baron P., Lipton J. M., Catania A. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukocyte Biol. 63:1998;740-745.
12. Dewitt D. A., Perry G., Cohen M., Doller C., Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149:1998;329-340.
13. Dickson D. W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:1997;321-339.
14. Dickson D. W., Lee S. C., Mattiace L. A., Yen S.-H. C., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
15. El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C., Loike J. D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
16. Frackowiak J., Wisniewski H. M., Wegiel J., Merz G. S., Iqbal K., Wang K. C. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol. 84:1992;225-233.
17. Frautschy S. A., Cole G. M., Baird A. Phagocytosis and deposition of vascular β-amyloid in rat brains injected with Alzheimer β-amyloid. Am. J. Pathol. 140:1992;1389-1399.
18. Garzon-Rodriguez W., Sepulveda-Becerra M., Milton S., Glabe C. G. Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272:1997;21037-21044.
19. Gasque P., Tenner A., Morgan B. P. Expression of the C1q/MBL/SPA receptor involved in phagocytosis and innate immune defense on human glia. Mol. Immunol. 35:1998;379.
20. Giulian D. Immune responses and dementia. Ann. N.Y. Acad. Sci. 835:1997;91-110.
21. Giulian D., Haverkamp L. J., Yu J., Karshin W., Tom D., Li J., Kazanskaia A., Kirkpatrick J., Roher A. E. The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J. Biol. Chem. 273:1998;29719-29726.
22. Goldsmith S. K., Wals P., Rozovsky I., Morgan T. E., Finch C. E. Kainic acid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain. J. Neurochem. 68:1997;2046-2052.
23. Goodwin J. L., Kehrli M. E. Jr., Uemura E. Integrin Mac-1 and beta-amyloid in microglial release of nitric oxide. Brain Res. 768:1997;279-286.
24. Goodwin J. L., Uemura E., Cunnick J. E. Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. Brain Res. 692:1995;207-214.
25. Guan E., Robinson S. L., Goodman E. B., Tenner A. J. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J. Immunol. 152:1994;4005-4016.
26. Haga S., Aizawa T., Ishii T., Ikeda K. Complement gene expression in mouse microglia and astrocytes in culture: Comparisons with mouse peritoneal macrophages. Neurosci. Lett. 216:1996;191-194.
27. Henson P. M. Interaction of cells with immune complexes: Adherence, release of constituents, and tissue injury. J. Exp. Med. 134:1971;114s.
28. Huang J., Kim L. J., Mealey R., Marsh H. C. Jr., Zhang Y., Tenner A. J., Connolly E. S. Jr., Pinsky D. J. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science. 285:1999;595-599.
29. Ii M., Sunamoto M., Ohnishi K., Ichimori Y. beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:1996;93-100.
30. Jiang H., Burdick D., Glabe C. G., Cotman C. W., Tenner A. J. β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152:1994;5050-5059.
31. Johnson S. A., Lampert-Etchells M., Pasinetti G. M., Rozovsky I., Finch C. E. Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging. 13:1992;641-648.
32. Korotzer A. R., Watt J., Cribbs D., Tenner A. J., Burdick D., Glabe C., Cotman C. W. Cultured rat microglia express C1q and receptor for C1q: Implications for amyloid effects on microglia. Exp. Neurol. 134:1995;214-221.
33. Krieger M., Acton S., Ashkenas J., Pearson A., Penman M., Resnick D. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268:1993;4569-4572.
34. Mazur-Kolecka B., Frackowiak J., Carroll R. T., Wisniewski H. M. Accumulation of Alzheimer amyloid-beta peptide in cultured myocytes is enhanced by serum and reduced by cerebrospinal fluid. J. Neuropathol. Exp. Neurol. 56:1997;263-272.
35. McDonald D. R., Brunden K. R., Landreth G. E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17:1997;2284-2294.
36. McGeer P. L., Akiyama H., Itagaki S., McGeer E. G. Immune system response in Alzheimer's Disease. Can. J. Neurol. Sci. 16:1989;516-527.
37. Meda L., Bernasconi S., Bonaiuto C., Sozzani S., Zhou D., Otvos L. Jr., Mantovani A., Rossi F., Cassatella M. A. Beta-amyloid (25-35) peptide and IFN-gamma synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J. Immunol. 157:1996;1213-1218.
38. Meda L., Bonaiuto C., Baron P., Otvos L. Jr., Rossi F., Cassatella M. A. Priming of monocyte respiratory burst by beta-amyloid fragment (25-35). Neurosci. Lett. 219:1996;91-94.
39. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi R. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 374:1995;647-650.
40. Mentlein R., Ludwig R., Martensen I. Proteolytic degradation of Alzheimer's disease amyloid beta-peptide by a metalloproteinase from microglial cells. J. Neurochem. 70:1998;721-726.
41. Murphy G. M. Jr., Yang L., Cordell B. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J. Biol. Chem. 273:1998;20967-20971.
42. Nakajima K., Shimojo M., Hamanoue M., Ishiura S., Sugita H., Kohsaka S. Identification of elastase as a secretory protease from cultured rat microglia. J. Neurochem. 58:1992;1401-1408.
43. Narita M., Holtzman D. M., Schwartz A. L., Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1997;1904-1911.
44. p, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity. 6:1997;119-129.
45. p, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells and platelets. J. Immunol. 160:1998;1929-1935.
46. Nolte C., Moller T., Walter T., Kettenmann H. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience. 73:1996;1091-1107.
47. Paresce D. M., Chung H., Maxfield F. R. Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272:1997;29390-29397.
48. Paresce D., Ghosh R. N., Maxfield F. R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
49. Pearson A. M. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 8:1996;20-28.
50. Perry V. H., Gordon S. Macrophages and the nervous system. Int. Rev. Cytol. 125:1991;203-441.
51. Qiu W. Q., Ye Z., Kholodenko D., Seubert P., Selkoe D. J. Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J. Biol. Chem. 272:1997;6641-6646.
52. Reid K. B., Lowe D. M., Porter R. R. Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera. Biochem. J. 130:1972;749-763.
53. Rogers J., Cooper N. R., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 89:1992;10016-10020.
54. Rogers J., Luber-Narod J., Styren S. D., Civin W. H. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol. Aging. 9:1988;339-349.
55. Rozovsky I., Morgan T. E., Willoughby D. A., Dugichi-Djordjevich M. M., Pasinetti G. M., Johnson S. A., Finch C. E. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience. 62:1994;741-758.
56. Sabo S., Lambert M. P., Kessey K., Wade W., Krafft G., Klein W. L. Interaction of beta-amyloid peptides with integrins in a human nerve cell line. Neurosci. Lett. 184:1995;25-28.
57. Savage M. J., Trusko S. P., Howland D. S., Pinsker L. R., Mistretta S., Reaume A. G., Greenberg B. D., Siman R., Scott R. W. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18:1998;1743-1752.
58. Shaffer L. M., Dority M. D., Gupta-Bansal R., Frederickson R. C., Younkin S. G., Brunden K. R. Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol. Aging. 16:1995;737-745.
59. Shaffer L. M., Dority M. D., Younkin S. G., Brunden K. R. Potential involvement of glia in amyloid β-peptide removal from the brain. Iqbal K., Mortimer J. A., Winblad B., Wisniewski H. M. Research Advances in Alzheimer's Disease and Related Disorders. 1995;629-635 Wiley, New York.
60. Shen Y., Li R., McGeer E. G., McGeer P. L. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769:1997;391-395.
61. Tenner A. J., Lesavre P. H., Cooper N. R. Purification and radiolabeling of human C1q. J. Immunol. 127:1981;648-653.
62. Terai K., Walker D. G., McGeer E. G., McGeer P. L. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 769:1997;385-390.
63. Ulvestad E., Williams K., Bjerkvig R., Tiekotter K., Antel J., Matre R. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukocyte Biol. 56:1994;732-740.
64. Van Furth R. Current view on the mononuclear phagocyte system. Immunobiology. 161:1982;178-185.
65. Van Muiswinkel F. L., Veerhuis R., Eikelenboom P. Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J. Neurochem. 66:1996;2468-2476.
66. Velazquez P., Cribbs D. H., Poulos T. L., Tenner A. J. Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis. Nat. Med. 3:1997;77-79.
67. Von Zahn J., Moller T., Kettenmann H., Nolte C. Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines. Neuroreport. 8:1997;3851-3856.
68. Walker D. G., Kim S. U., McGeer P. L. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40:1995;478-493.
69. Walker D. G., McGeer P. L. Complement gene expression in human brain: Comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14:1992;109-116.
70. Walker D. G., Yasuhara O., Patston P. A., McGeer E. G., McGeer P. L. Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease. Brain Res. 675:1995;75-82.
71. Webster S., Bonnell B., Rogers J. Charge based binding of complement component C1q to the Alzheimer amyloid β-peptide. Am. J. Pathol. 150:1997;1531-1536.
72. Webster S., Lue L.-F., Brachova L., Tenner A. J., McGeer P. L., Terai K., Walker D. G., Bradt B., Cooper N. R., Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging. 18:1997;415-421.
73. Webster S., Rogers J. Relative efficacies of amyloid beta peptide (A beta) binding proteins in A beta aggregation. J. Neurosci. Res. 46:1996;58-66.
74. p, the C1q receptor that enhances phagocytosis, J. Leukocyte Biol, in press.
75. Webster S. D., Tenner A. J., Poulos T. L., Cribbs D. H. The mouse C1q A chain sequence alters beta amyloid induced complement activation. Neurobiol. Aging. 20:1999;297-304.
76. Wegiel J., Wisniewski H. M. The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol. (Berl.). 81:1990;116-124.
77. Weldon D. T., Rogers S. D., Ghilardi J. R., Finke M. P., Cleary J. P., O'Hare E., Esler W. P., Maggio J. E., Mantyh P. W. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. Neuroscience. 18:1998;2161-2173.
78. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
79. Yao J., Harvath L., Gilbert D. L., Colton C. A. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27:1990;36-42.
80. Yao J., Keri J. E., Taffs R. E., Colton C. A. Characterization of interleukin-1 production by microglia in culture. Brain Res. 591:1992;88-93.
81. Young K. R. Jr., Ambrus J. L. Jr., Malbran A., Fauci A. S., Tenner A. J. Complement subcomponent C1q stimulates Ig production by human B lymphocytes. J. Immunol. 146:1991;3356-3364.